Employees Retirement System of Texas trimmed its holdings in shares of Boston Scientific Corporation (NYSE:BSX) by 0.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 534,400 shares of the medical equipment provider’s stock after selling 2,000 shares during the period. Employees Retirement System of Texas’ holdings in Boston Scientific Corporation were worth $14,814,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of BSX. BlackRock Inc. boosted its holdings in Boston Scientific Corporation by 2,181.6% during the first quarter. BlackRock Inc. now owns 95,744,545 shares of the medical equipment provider’s stock worth $2,381,169,000 after buying an additional 91,548,235 shares in the last quarter. FMR LLC boosted its holdings in Boston Scientific Corporation by 7.6% during the first quarter. FMR LLC now owns 184,708,390 shares of the medical equipment provider’s stock worth $4,593,698,000 after buying an additional 13,105,596 shares in the last quarter. Jennison Associates LLC boosted its holdings in Boston Scientific Corporation by 405.3% during the second quarter. Jennison Associates LLC now owns 10,639,290 shares of the medical equipment provider’s stock worth $294,921,000 after buying an additional 8,533,655 shares in the last quarter. MARSHALL WACE ASIA Ltd bought a new stake in Boston Scientific Corporation during the first quarter worth approximately $149,859,000. Finally, Marshall Wace North America L.P. bought a new stake in Boston Scientific Corporation during the first quarter worth approximately $149,859,000. Hedge funds and other institutional investors own 90.44% of the company’s stock.

WARNING: “Employees Retirement System of Texas Trims Position in Boston Scientific Corporation (BSX)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/09/30/employees-retirement-system-of-texas-trims-position-in-boston-scientific-corporation-bsx.html.

BSX has been the subject of a number of research reports. Royal Bank Of Canada raised their target price on shares of Boston Scientific Corporation from $29.00 to $31.00 and gave the stock an “outperform” rating in a report on Friday, June 9th. BidaskClub upgraded shares of Boston Scientific Corporation from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 10th. Wells Fargo & Company restated an “outperform” rating and set a $31.00 target price (up from $29.50) on shares of Boston Scientific Corporation in a report on Friday, June 16th. BMO Capital Markets restated a “buy” rating and set a $30.00 target price on shares of Boston Scientific Corporation in a report on Wednesday, June 21st. Finally, Needham & Company LLC raised their target price on shares of Boston Scientific Corporation from $30.00 to $32.00 and gave the stock a “buy” rating in a report on Thursday, June 22nd. One analyst has rated the stock with a sell rating, five have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $29.88.

In other news, SVP John Bradley Sorenson sold 2,100 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $27.15, for a total value of $57,015.00. Following the completion of the transaction, the senior vice president now owns 18,880 shares in the company, valued at $512,592. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Timothy A. Pratt sold 10,104 shares of the company’s stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $27.46, for a total transaction of $277,455.84. Following the completion of the transaction, the executive vice president now owns 185,742 shares of the company’s stock, valued at approximately $5,100,475.32. The disclosure for this sale can be found here. Insiders sold 259,757 shares of company stock valued at $7,078,084 in the last quarter. Corporate insiders own 0.74% of the company’s stock.

Boston Scientific Corporation (NYSE BSX) traded up 1.50% during midday trading on Friday, reaching $29.17. 4,984,014 shares of the company’s stock were exchanged. Boston Scientific Corporation has a 1-year low of $19.67 and a 1-year high of $29.40. The firm’s 50-day moving average is $27.39 and its 200 day moving average is $26.61. The stock has a market cap of $40.02 billion, a P/E ratio of 52.18 and a beta of 1.09.

Boston Scientific Corporation (NYSE:BSX) last released its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.32 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.31 by $0.01. The company had revenue of $2.26 billion during the quarter, compared to analysts’ expectations of $2.21 billion. Boston Scientific Corporation had a net margin of 9.04% and a return on equity of 23.62%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.27 earnings per share. Equities analysts anticipate that Boston Scientific Corporation will post $1.26 earnings per share for the current fiscal year.

About Boston Scientific Corporation

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.

Institutional Ownership by Quarter for Boston Scientific Corporation (NYSE:BSX)

Receive News & Stock Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related stocks with our FREE daily email newsletter.